Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Nephros (NEPH) Accumulated Depreciation & Amortization (2016 - 2025)

Nephros has reported Accumulated Depreciation & Amortization over the past 15 years, most recently at $1.1 million for Q4 2025.

  • Quarterly results put Accumulated Depreciation & Amortization at $1.1 million for Q4 2025, up 5.45% from a year ago — trailing twelve months through Dec 2025 was $1.1 million (up 5.45% YoY), and the annual figure for FY2025 was $1.1 million, up 5.45%.
  • Accumulated Depreciation & Amortization for Q4 2025 was $1.1 million at Nephros, up from $1.0 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for NEPH hit a ceiling of $1.1 million in Q4 2025 and a floor of $829000.0 in Q4 2021.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $962000.0 (2023), compared with a mean of $957400.0.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: decreased 1.66% in 2021 and later grew 11.34% in 2022.
  • Nephros' Accumulated Depreciation & Amortization stood at $829000.0 in 2021, then grew by 11.34% to $923000.0 in 2022, then increased by 4.23% to $962000.0 in 2023, then rose by 4.89% to $1.0 million in 2024, then grew by 5.45% to $1.1 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $1.1 million (Q4 2025), $1.0 million (Q4 2024), and $962000.0 (Q4 2023) per Business Quant data.